Stay updated with breaking news from Igor Astsaturov. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Webinar Wednesdays is planned to be held on the last Wednesday of each month - starting on Wednesday, April 24th with the first webinar on the increasing prevalence of non-small cell lung cancer in...
Preclinical data showed that LP-184 shrunk tumors in vivo by more than 90% in just 8 weeks.
Igor Astsaturov, MD, PhD, has been appointed inaugural holder of the Paul F. Engstrom Professorship in Oncology.
14.09.2022 - Lantern Pharma Inc. (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR artificial intelligence ('A.I.') and machine learning (“M.L.”) platform to transform the cost, pace, and timeline of oncology drug discovery ... Seite 1
/PRNewswire/ -- Lantern Pharma (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR® artificial intelligence ("A.I.") platform...